Drug Search Results
More Filters [+]

Methacholine chloride

Alternative Names: methacholine chloride, provocholine
Latest Update: 2023-11-02
Latest Update Note: Clinical Trial Update

Product Description

Methacholine Chloride is the chloride salt form of methacholine, a direct-acting cholinergic muscarinic agonist with bronchoconstrictive, miotic, vasodilator, and cardiac vagomimetic activity. Methacholine chloride acts directly on the muscarinic receptors in the heart, eye, and lung, thereby producing parasympathomimetic effects. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Methacholine-chloride)

Mechanisms of Action: mAChR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Inhalant

FDA Designation: None *

Approval Status: Approved

Approved Countries: Canada | Chile | Denmark | Greece | Israel | Japan | Korea | Norway | Spain | Taiwan | United Kingdom | United States

Approved Indications: Asthma | Bronchial Hyperreactivity

Known Adverse Events: Headache

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Methacholine chloride

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events